NASDAQ:GHSIGuardion Health Sciences Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Guardion Health Sciences Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.44 -0.01 (-2.25 %) (As of 07/1/2020 04:00 PM ET) Add Compare Share Today's Range$0.43Now: $0.44▼$0.4650-Day Range$0.43MA: $0.48▼$0.5552-Week Range$0.17Now: $0.44▼$3.05Volume3.68 million shsAverage Volume7.78 million shsMarket Capitalization$37.54 millionP/E RatioN/ADividend YieldN/ABeta-0.12 ProfileAdvanced ChartCompetitorsEarningsInstitutional OwnershipHeadlinesSocial Media Guardion Health Sciences, Inc., a specialty health sciences company, develops, formulates, and distributes condition-specific medical foods in the United States and internationally. It operates in two segments, Medical Foods and Vision Testing Diagnostics. The Medical Foods segment offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; MapcatSF, a medical device that measures the macular pigment optical density; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. The Vision Testing Diagnostics segment develops, manufactures, and sells equipment and supplies for standardized vision testing for use by eye doctors in clinical trials, real-world vision evaluation, and industrial vision testing. Its products include VectorVision CSV-1000, an instrument for contrast sensitivity testing; and ESV-3000 ETDRS, a device for early treatment diabetic retinopathy study in visual acuity testing. The company distributes its products through direct sales force, as well as through its guardionhealth.com Website. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Guardion Health Sciences. Previous Next 2.5 Community Rank Outperform VotesGuardion Health Sciences has received 56 “outperform” votes. (Add your “outperform” vote.)Underperform VotesGuardion Health Sciences has received 56 “underperform” votes. (Add your “underperform” vote.)Community SentimentGuardion Health Sciences has received 50.00% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Guardion Health Sciences and other stocks. Vote “Outperform” if you believe GHSI will outperform the S&P 500 over the long term. Vote “Underperform” if you believe GHSI will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldGuardion Health Sciences does not currently pay a dividend.Dividend GrowthGuardion Health Sciences does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Guardion Health Sciences insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 8.47% of the stock of Guardion Health Sciences is held by insiders.Percentage Held by InstitutionsOnly 1.66% of the stock of Guardion Health Sciences is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Book Value per Share RatioGuardion Health Sciences has a P/B Ratio of 2.74. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.50 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:GHSI Previous Symbol CUSIPN/A CIKN/A Webwww.guardionhealth.com Phone858-605-9055Debt Debt-to-Equity Ratio0.03 Current Ratio12.46 Quick Ratio11.80Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$900,000.00 Price / Sales41.72 Cash FlowN/A Price / Cash FlowN/A Book Value$0.16 per share Price / Book2.74Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-10,880,000.00 Net Margins-1,307.08% Return on Equity-123.03% Return on Assets-110.66%Miscellaneous Employees19 Outstanding Shares85,620,000Market Cap$37.54 million Next Earnings Date8/10/2020 (Estimated) OptionableNot Optionable NASDAQ:GHSI Rates by TradingView Receive GHSI News and Ratings via Email Sign-up to receive the latest news and ratings for GHSI and its competitors with MarketBeat's FREE daily newsletter. Guardion Health Sciences (NASDAQ:GHSI) Frequently Asked Questions How has Guardion Health Sciences' stock been impacted by COVID-19 (Coronavirus)? Guardion Health Sciences' stock was trading at $0.39 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, GHSI shares have increased by 12.4% and is now trading at $0.4385. View which stocks have been most impacted by Coronavirus. When is Guardion Health Sciences' next earnings date? Guardion Health Sciences is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020. View our earnings forecast for Guardion Health Sciences. How were Guardion Health Sciences' earnings last quarter? Guardion Health Sciences Inc (NASDAQ:GHSI) posted its quarterly earnings results on Monday, August, 12th. The company reported ($0.14) EPS for the quarter. The business had revenue of $0.26 million for the quarter. Guardion Health Sciences had a negative net margin of 1,307.08% and a negative return on equity of 123.03%. View Guardion Health Sciences' earnings history. Has Guardion Health Sciences been receiving favorable news coverage? Headlines about GHSI stock have been trending very negative on Thursday, according to InfoTrie Sentiment. The research group ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Guardion Health Sciences earned a coverage optimism score of -3.3 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news about Guardion Health Sciences. Who are some of Guardion Health Sciences' key competitors? Some companies that are related to Guardion Health Sciences include CELYAD SA/ADR (CYAD), BIOFRONTERA AG/ADR (BFRA), Gemphire Therapeutics (GEMP), Evofem Biosciences (EVFM), InflaRx (LUMO), Minerva Neurosciences (NERV), Iterum Therapeutics (NRBO), Mustang Bio (MBIO), Harrow Health (HROW), Rockwell Medical (RMTI), PhaseBio Pharmaceuticals (PHAS), ESSA Pharma (EPIX), Sierra Oncology (SRRA), Conatus Pharmaceuticals (CNAT) and Arbutus Biopharma (ABUS). View all competitors. What other stocks do shareholders of Guardion Health Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Guardion Health Sciences investors own include Ibio (IBIO), VBI Vaccines (VBIV), Biocept (BIOC), Co-Diagnostics (CODX), Onconova Therapeutics (ONTX), vTv Therapeutics (VTVT), Vaxart (VXRT), FuelCell Energy (FCEL), Tonix Pharmaceuticals (TNXP) and Nokia Oyj (NOK). Who are Guardion Health Sciences' key executives? Guardion Health Sciences' management team includes the following people: Michael Favish, Pres, CEO & Chairman (Age 70)Mr. John W. Townsend, Controller & Chief Accounting Officer (Age 57)Dr. David W. Evans, Chief Science Officer & Director (Age 63)Mr. Vincent J. Roth, Gen. Counsel & Corp. Sec. (Age 51) When did Guardion Health Sciences IPO? (GHSI) raised $6 million in an initial public offering on Friday, April 5th 2019. The company issued 1,500,000 shares at a price of $4.00 per share. WallachBeth Capital and Westpark Capital acted as the underwriters for the IPO. What is Guardion Health Sciences' stock symbol? Guardion Health Sciences trades on the NASDAQ under the ticker symbol "GHSI." How do I buy shares of Guardion Health Sciences? Shares of GHSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Guardion Health Sciences' stock price today? One share of GHSI stock can currently be purchased for approximately $0.44. How big of a company is Guardion Health Sciences? Guardion Health Sciences has a market capitalization of $37.54 million and generates $900,000.00 in revenue each year. Guardion Health Sciences employs 19 workers across the globe. What is Guardion Health Sciences' official website? The official website for Guardion Health Sciences is www.guardionhealth.com. How can I contact Guardion Health Sciences? Guardion Health Sciences' mailing address is 15150 AVENUE OF SCIENCE SUITE 200, SAN DIEGO CA, 92128. The company can be reached via phone at 858-605-9055 or via email at [email protected] This page was last updated on 7/2/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
